Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: A report of CALGB 9082, SWOG 9114, and NCIC MA-13

William P. Peters, Gary L. Rosner, James J. Vredenburgh, Elizabeth J. Shpall, Michael Crump, Paul G. Richardson, Michael W. Schuster, Lawrence B. Marks, Constance Cirrincione, Larry Norton, I. C. Henderson, Richard L. Schilsky, David D. Hurd

Research output: Contribution to journal › Article › peer-review

98 Scopus citations

Fingerprint

Dive into the research topics of 'Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: A report of CALGB 9082, SWOG 9114, and NCIC MA-13'. Together they form a unique fingerprint.

Medicine & Life Sciences